0. Introduction
Cannabis: therapeutic or recreational drug
Section 1. Botany, pharmacognosy, pharmacology and recreational use of the cannabis plant
Lecture 1.1. History of cannabis, from its origins to today’s products
Prof. Javier Muriel Serrano, Department of Pharmacology, Pediatrics and Organic Chemistry, Universidad Miguel Hernández, Spain
Lecture 1.2. Taxonomy and botany of cannabis. Macroscopic and microscopic characteristics
Prof. Javier Muriel Serrano, Department of Pharmacology, Pediatrics and Organic Chemistry, Universidad Miguel Hernández, Spain
Lecture 1.3. Phytochemistry of cannabis: main families of compounds and their main pharmacological uses
Prof. Javier Muriel Serrano, Department of Pharmacology, Pediatrics and Organic Chemistry, Universidad Miguel Hernández, Spain
Lecture 1.4. Main analytical techniques for the characterization of cannabis compounds. Good Laboratory Practices (GLP)
Prof. Enrique Barrajón Catalán, Institute for Research, Development and Innovation in Health Biotechnology of Elche (IDiBE), Universidad Miguel Hernández, Spain
Lecture 1.5. Techniques for the extraction of active compounds from cannabis
Prof. Enrique Barrajón Catalán, Institute for Research, Development and Innovation in Health Biotechnology of Elche (IDiBE), Universidad Miguel Hernández, Spain
Lecture 1.6. Pharmacology of cannabinoids (endogenous ligands, receptors, synthesis and degradation enzymes)
Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 1.7. Cannabinoid signaling in the brain: extracting specificity from ubiquity
Prof. Giovanni Marsicano, NeuroCentre Magendie INSERM, University of Bordeaux, France
Section 2. Alterations of the cannabinoid system in animal experimentation and clinical pathology
Lecture 2.1. Endocannabinoid system components as potential biomarkers
Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.2. Immunohistochemistry, conventional and confocal microscopy, western blots
Prof. Daniela Navarro, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.3. Methodology for detecting changes in ECS components: gene expression, polymorphisms and epigenetics
Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.4. Methodology for detecting changes in ECS components: biochemistry
Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.5. Methods for detecting changes in the ECS components: neuroimaging
Prof. Silvia de Santis, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.6. Alterations of the endocannabinoid system in gastrointestinal diseases
Prof. Ani Gasparyan Hovhannisyan, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.7. Alterations of the endocannabinoid system in liver diseases
Prof. Daniela Navarro, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.8. Alterations of the endocannabinoid system in renal diseases
Prof. María Salud García Gutiérrez, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.9. Alterations of the endocannabinoid system in endrocrinology
Prof. Ani Gasparyan Hovhannisyan, Institute of Neurosciences, CSIC/Universidad Miguel Hernández
Lecture 2.10. Alterations of the endocannabinoid system in respiratory diseases
Prof. Daniela Navarro, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.11. Alterations of the endocannabinoid system in oncology
Prof. Ana Lucía Yuste, Department of Oncology, Hospital General de Alicante, Spain
Lecture 2.12. Changes in the endocannabinoid system in pain and inflammation
Prof. Katarzyna Starowicz, Maj Institute of Pharmacology Polish Academy of Sciences, Poland
Lecture 2.13. Alterations of the endocannabinoid system in neurology
Prof. Ani Gasparyan Hovhannisyan, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 2.14. Alterations of the endocannabinoid system in psychiatry
Prof. María Salud García Gutiérrez, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Section 3. Therapeutic uses of cannabinoid derivatives I (pain, neurology and psychiatry)
Lecture 3.1. Therapheutic applications of cannabinoids in pain management
Prof. Raquel Saldaña, Anaesthesia Section at Hospital 12 De Octubre, Spain
Lecture 3.2. Therapheutic applications of cannabinoids in the management of neuropathic pain
Prof. Katarzyna Starowicz. Maj Institute of Pharmacology Polish Academy of Sciences, Poland
Lecture 3.3. Cannabinoid therapy in epilepsy and epileptic syndromes
Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 3.4. Multiple sclerosis: role of cannabinoids in treatment and pathophysiological aspects
Prof. María Salud García Gutiérrez, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 3.5. Cannabinoids and extrapyramidal pathology: Parkinson’s disease and other extrapyramidal diseases (dystonia, Gilles Tourette syndrome, tics, etc.)
Prof. Ani Gasparyan Hovhannisyan, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 3.6. Role of cannabinoids in migraine
Prof. Daniela Navarro, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 3.7. Therapeutic usefulness of cannabinoids in anxiety and depressive disorders
Prof. María Salud García Gutiérrez, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 3.8. Role of cannabinoid CB2 receptor in the regulation of emotional and addictive behaviors
Prof. Jorge Manzanares Robles, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 3.9. Role of cannabidiol and sertraline in regulating behavioral and brain gene expression changes in a novel animal model of posttraumatic stress disorder
Prof. Jorge Manzanares Robles, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 3.10. Role of cannabidiol in drug dependence
Prof. Jorge Manzanares Robles, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Section 4. Therapeutic uses of cannabinoid derivatives II
Lecture 4.1. Regulation of the immune system by cannabinoids: inflammation and infection
Prof. Esther Caparrós Cayuela, Department Clinical Medicine, CSIC/Universidad Miguel Hernández, Spain
Lecture 4.2. Effect of cannabinoids in different immune system pathologies
Prof. Esther Caparrós Cayuela, Department Clinical Medicine, CSIC/Universidad Miguel Hernández, Spain
Lecture 4.3. Cannabinoid system-intestinal microbiome relationship: physiology and pathology
Prof. Esther Caparrós Cayuela, Department Clinical Medicine, CSIC/Universidad Miguel Hernández, Spain
Lecture 4.4. Utility of cannabinoid therapy in cardiovascular pathology
Prof. María Salud García Gutiérrez, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 4.5.Role of the endocannabinoid system in energy balance and obesity
Prof. Daniela Cota, NeuroCentre Magendie INSERM, University of Bordeaux, France
Lecture 4.6. Therapeutic potential of the use of cannabinoid compounds in the treatment of renal pathologies
Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 4.7. Potential therapeutic utility of cannabinoid compounds in liver diseases
Prof. Ani Gasparyan Hovhannisyan, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 4.8. Potential therapeutic utility of cannabinoid compounds in respiratory pathologies
Prof. Daniela Navarro, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 4.9. Usefulness of the use of cannabinoids in traumatology
Prof. Daniela Navarro, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 4.10. Effects of cannabinoids on bone tissue
Prof. Daniela Navarro, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 4.11. Potential therapeutic utility of cannabinoid compounds in genitourinary disorders
Prof. Ani Gasparyan Hovhannisyan, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 4.12. Therapeutic potential of the use of cannabinoid compounds in the treatment of ophthalmologic pathologies
Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Lecture 4.13. Cannabinoids in dermatology
Prof. María Salud García Gutiérrez, Institute of Neurosciences, CSIC/Universidad Miguel Hernández, Spain
Section 5. Patents and cannabinoid research seminar
Patent Seminar: Patents related to cannabinoid compounds
Prof. Ramón Soto, National Autonomous University of Mexico, Mexico
Research Seminar: Genetically modified mice in neuropsychopharmacology research
Prof. Jan Rodríguez Parkitna, Maj Institute of Pharmacology Polish Academy of Sciences, Poland